Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by DJDawg on Aug 15, 2024 9:45am

warrants

Just a friendly reminder that in 2 weeks a massive 57.5 million chunk of warrants expire. That is equal to about 25% of the total float. That is a big lump of shares.

I feel that that change in share dilution risk has to matter in some way. Makes for an interesting question as to what Sept will look like with the trading.


Comment by chry200030 on Aug 15, 2024 9:56am
That's too bad. It means we could be seeng more cheap PP's ahead...
Comment by N0taP00p on Aug 15, 2024 10:26am
Glass Half Full: Less risk of dilution through conversion, low share count attractive for a future acquisition, etc Glass Half Empty:  Harder to get funding via PP since no one's made money on warrants for as long as I can remember.  Personally, I'm ok with the warrants expiring and BTD news coming after the expiration.  Purely selfish perspective.  If I'm RDW ...more  
Comment by riverrrow on Aug 15, 2024 1:06pm
Apparently the last day to instruct TD that you want to exercise your tradeable TLT warrants was yesterday.  The CRA (and their Uber boss) are going to be very disappointed in my 2024 tax return.  No capital gains tax!
Comment by DJDawg on Aug 15, 2024 1:37pm
Interesting. Thanks for sharing
Comment by DJDawg on Aug 15, 2024 6:40pm
Questrade says warrants can be exercised with 72hrs notice. So if the warrants are end of August then would that not make Aug 27 the last day. Just curious?
Comment by chry200030 on Aug 15, 2024 7:23pm
Aug 22 expiry., based on the info in T.D Waterhouse.
Comment by StevenBirch on Aug 15, 2024 8:21pm
I would be surprised if the warrants can't be exercised any time up to and including Aug 22. If a particular broker puts an earlier deadline I don't know anything about that but that was never normal practice.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250